Long-term treatment outcome of tamsulosin for benign prostatic hyperplasia.
about
Silodosin for benign prostatic hyperplasia.Six-year follow up of silodosin monotherapy for the treatment of lower urinary tract symptoms suggestive of benign prostatic hyperplasia: What are the factors for continuation or withdrawal?Clinical impact of tamsulosin on generic and symptom-specific quality of life for benign prostatic hyperplasia patients: using international prostate symptom score and Rand Medical Outcomes Study 36-item Health Survey.Long-term outcome of tamsulosin for patients with lower urinary tract symptoms according to the treatment response defined by lower urinary tract symptom outcomes score.How frequent are invasive therapies required in patients receiving tamsulosin for benign prostatic hyperplasia? A retrospective long-term study.
P2860
Long-term treatment outcome of tamsulosin for benign prostatic hyperplasia.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Long-term treatment outcome of tamsulosin for benign prostatic hyperplasia.
@en
Long-term treatment outcome of tamsulosin for benign prostatic hyperplasia.
@nl
type
label
Long-term treatment outcome of tamsulosin for benign prostatic hyperplasia.
@en
Long-term treatment outcome of tamsulosin for benign prostatic hyperplasia.
@nl
prefLabel
Long-term treatment outcome of tamsulosin for benign prostatic hyperplasia.
@en
Long-term treatment outcome of tamsulosin for benign prostatic hyperplasia.
@nl
P2093
P2860
P1476
Long-term treatment outcome of tamsulosin for benign prostatic hyperplasia.
@en
P2093
Akito Terai
Hiroki Ohara
Kentaro Ichioka
Koji Yoshimura
Naoki Terada
Yoichi Arai
Yoshiyuki Matsui
P2860
P304
P356
10.1111/J.1442-2042.2004.00913.X
P577
2004-10-01T00:00:00Z